List of works - Vittorio Maglione

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease.

scientific article

Cavernous angiomas of the nervous system in Italy: clinical and genetic study

article

Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington disease

scientific article

DNA instability in replicating Huntington's disease lymphoblasts

scientific article

De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease

scientific article published on 19 December 2017

Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease

scientific article

FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.

scientific article published on 2 December 2013

Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice

scientific article

Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells.

scientific article published on 26 April 2011

Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington's disease

scientific article published on August 2006

Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease

scientific article published in September 2017

Glycosphingolipid metabolic reprogramming drives neural differentiation

scientific article

Highly disabling cerebellar presentation in Huntington disease.

scientific article published in July 2003

Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutations.

scientific article

Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course

scientific article

Impaired Levels of Gangliosides in the Corpus Callosum of Huntington Disease Animal Models

scientific article published on 6 October 2016

Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1.

scientific article published on March 2010

Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease

scientific article published on 24 January 2017

Italian Huntington disease patients--data and tissue bank.

scientific article

MRI measures of corpus callosum iron and myelin in early Huntington's disease.

scientific article published on 15 October 2013

Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington's disease transgenic R6/2 (160 CAG) mice

scientific article published on 17 February 2017

Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations

scientific article

New Therapeutic Drugs from Bioactive Natural Molecules: the Role of Gut Microbiota Metabolism in Neurodegenerative Diseases

scientific article published on 3 April 2018

Nitric oxide dysregulation in platelets from patients with advanced Huntington disease.

scientific article

Onset and pre-onset studies to define the Huntington's disease natural history.

scientific article

Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model

scientific article

Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model

scientific article published on 14 February 2017

Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation

scientific article published on 9 November 2005

Terapeutic Potential of Microencapsulated Sertoli Cells in Huntington Disease

scientific article published on 26 May 2016

The Corticospinal Tract in Huntington's Disease.

scientific article published on 4 April 2014

The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum-microglia crosstalk preventing disease progression in a mouse model of Huntington's disease

scientific article published on 18 July 2020

The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea.

scientific article published on 10 October 2005

Tractography of the corpus callosum in Huntington's disease

scientific article

ZPLD1 gene is disrupted in a patient with balanced translocation that exhibits cerebral cavernous malformations.

scientific article

List of works by Vittorio Maglione

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease.

Cavernous angiomas of the nervous system in Italy: clinical and genetic study

Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington disease

DNA instability in replicating Huntington's disease lymphoblasts

De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease

Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease

FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.

Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice

Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells.

Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington's disease

Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease

Glycosphingolipid metabolic reprogramming drives neural differentiation

Highly disabling cerebellar presentation in Huntington disease.

Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutations.

Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course

Impaired Levels of Gangliosides in the Corpus Callosum of Huntington Disease Animal Models

Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1.

Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease

Italian Huntington disease patients--data and tissue bank.

MRI measures of corpus callosum iron and myelin in early Huntington's disease.

Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington's disease transgenic R6/2 (160 CAG) mice

Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations

New Therapeutic Drugs from Bioactive Natural Molecules: the Role of Gut Microbiota Metabolism in Neurodegenerative Diseases

Nitric oxide dysregulation in platelets from patients with advanced Huntington disease.

Onset and pre-onset studies to define the Huntington's disease natural history.

Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model

Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model

Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation

Terapeutic Potential of Microencapsulated Sertoli Cells in Huntington Disease

The Corticospinal Tract in Huntington's Disease.

The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum-microglia crosstalk preventing disease progression in a mouse model of Huntington's disease

The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea.

Tractography of the corpus callosum in Huntington's disease

ZPLD1 gene is disrupted in a patient with balanced translocation that exhibits cerebral cavernous malformations.